Enveric Biosciences Inc (ENVB)
0.9672
+0.06
(+6.43%)
USD |
NASDAQ |
May 08, 16:00
0.9301
-0.04
(-3.84%)
After-Hours: 19:39
Enveric Biosciences Cash from Operations (Quarterly): -1.751M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.751M |
| September 30, 2023 | -2.740M |
| June 30, 2023 | -4.466M |
| March 31, 2023 | -5.137M |
| December 31, 2022 | -3.462M |
| September 30, 2022 | -4.550M |
| June 30, 2022 | -4.585M |
| March 31, 2022 | -4.549M |
| December 31, 2021 | -4.067M |
| September 30, 2021 | -2.206M |
| June 30, 2021 | -2.022M |
| March 31, 2021 | -3.162M |
| December 31, 2020 | -2.25M |
| September 30, 2020 | -0.3937M |
| June 30, 2020 | 1.048M |
| March 31, 2020 | -2.293M |
| December 31, 2019 | -0.979M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.49M |
| March 31, 2019 | -0.9841M |
| December 31, 2018 | -1.003M |
| September 30, 2018 | -1.283M |
| June 30, 2018 | 0.1802M |
| March 31, 2018 | -0.4596M |
| December 31, 2017 | -0.9412M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0986M |
| June 30, 2017 | -0.8631M |
| March 31, 2017 | -0.8379M |
| December 31, 2016 | 0.2936M |
| September 30, 2016 | -2.831M |
| June 30, 2016 | -0.3193M |
| March 31, 2016 | 0.1531M |
| September 30, 2015 | -3.248M |
| June 30, 2015 | -1.072M |
| March 31, 2015 | -0.0012M |
| December 31, 2014 | -0.004M |
| September 30, 2014 | 0.0013M |
| June 30, 2014 | -0.0127M |
| March 31, 2014 | -0.0278M |
| December 31, 2013 | -0.0004M |
| September 30, 2013 | -0.0052M |
| June 30, 2013 | -0.0037M |
| March 31, 2013 | -0.0122M |
| December 31, 2012 | -0.0038M |
| September 30, 2012 | -0.0051M |
| June 30, 2012 | -0.0039M |
| March 31, 2012 | -0.0121M |
| December 31, 2011 | -0.0048M |
| September 30, 2011 | -0.0037M |
| June 30, 2011 | -0.0049M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.137M
Minimum
Mar 2023
1.048M
Maximum
Jun 2020
-2.529M
Average
-2.293M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Seelos Therapeutics Inc | -1.911M |
| Societal CDMO Inc (DELISTED) | 1.527M |
| Cardiff Oncology Inc | -7.74M |
| BioVie Inc | -5.910M |
| Adial Pharmaceuticals Inc | -1.223M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.1861M |
| Free Cash Flow | -14.10M |
| Free Cash Flow Per Share (Quarterly) | -0.7664 |
| Free Cash Flow Yield | -675.3% |